RH Bophelo is proud to announce the release of its Integrated Annual Report 2026, themed Capital That Heals. This report marks a defining chapter in the Company’s journey, showcasing how disciplined capital allocation continues to generate sustainable shareholder value while strengthening healthcare access across South Africa.
Building on recent momentum, the report highlights RH Bophelo’s evolution into an integrated healthcare investment company. By investing across the healthcare value chain, from hospitals and diagnostics to renal care, pharmaceutical distribution and healthcare financing, the Company is building a connected ecosystem to improve patient outcomes and support long-term growth.
Investing Capital with Purpose
At RH Bophelo, capital is more than a financial resource. It is a catalyst for expanding access to quality healthcare, supporting innovation and building resilient healthcare businesses that create long-term value.
Throughout the 2026 financial year, the Company continued to advance its asset-light investment strategy, strengthening high-growth healthcare platforms that complement its established hospital portfolio. This approach enables RH Bophelo to deploy capital more efficiently, unlock new revenue opportunities and create lasting value for shareholders and the communities it serves.
Today, the Company’s portfolio spans the patient journey, supporting healthcare delivery through diagnostics, renal services, pharmaceutical distribution, healthcare financing and hospital operations, all guided by a shared commitment to improving access to quality care.
Asset-Light Investments Continue to Gain Traction
RH Bophelo’s asset-light strategy continued to gain traction during the year, reinforcing the Company’s commitment to building scalable healthcare platforms that extend beyond traditional hospital infrastructure. Continued investment in diagnostic imaging, renal care, pharmaceutical distribution and healthcare financing has strengthened the Group’s integrated healthcare ecosystem while creating new opportunities for sustainable growth. By expanding into these complementary healthcare services, RH Bophelo is improving patient access, enhancing operational efficiency and positioning the business to deliver resilient, long-term value in an evolving healthcare landscape.
Creating Sustainable Value
Despite a challenging operating environment, RH Bophelo delivered a resilient performance and remained focused on long-term value creation.
Highlights for the year include:
- Net Asset Value increased to R1.097 billion, with Net Asset Value per share increasing to R16.96.
- Portfolio revenue grew to approximately R1.18 billion, supported by continued expansion across both hospital and asset-light businesses.
- Strategic growth continued across diagnostic imaging, renal care, pharmaceutical distribution and innovative healthcare financing solutions.
- The successful refinancing of the Norsad Capital facility strengthened the Company’s balance sheet and enhanced financial flexibility for future growth.
These achievements reflect the continued execution of RH Bophelo’s long-term strategy and its disciplined approach to investing in scalable healthcare opportunities.
Looking Ahead
As healthcare continues to evolve, RH Bophelo remains committed to identifying opportunities that improve access and create sustainable value. The Company will continue to expand its healthcare ecosystem through strategic partnerships, innovative solutions, and disciplined investment, positioning itself to meet the changing needs of patients, healthcare providers, and investors.
The RH Bophelo Integrated Annual Report 2026 provides a comprehensive overview of the Company’s financial performance, strategic progress, governance practices and future outlook. We invite shareholders, investors, partners and stakeholders to explore this year’s report and discover how Capital That Heals is shaping the future of healthcare investment.
